Skip to main content
Fig. 7 | Journal for ImmunoTherapy of Cancer

Fig. 7

From: Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer

Fig. 7

Targeting CD47 and VEGF significantly prolonged the median survival of NSCLC-bearing mice. a Immunohistochemistry CD68 staining of NCI-H1975 tumor tissues. b and c A549 metastatic model (b) and NCI-H1975 metastatic model (c) were constructed to challenge the effects of VEGFR1-SIRPα on the survival (N = 5 per group). d The description of combined anti-angiogenic and CD47-blocking therapies eliciting potent anti-tumor effect in NSCLC

Back to article page